Benefit-Risk SIG

The Benefit-Risk SIG was set up at the start of 2012 to help support those involved in this fast evolving area.

The main aims of the SIG are:

• To understand how best to apply Benefit-Risk Methodologies across the Pharmaceutical Industry
• To discuss and make recommendations on key methodological issues
• To share examples of how Benefit-Risk has been used within pharmaceutical companies
• To share external information including new developments around Benefit-Risk

Currently the SIG has subgroups working on:
 
• Literature review
• Points to consider for creating effects tables
• MCDA/SMAA
• Benefit-Risk in the HTA setting (together with the HTA SIG)
• Training
• Bayesian applications in Benefit-Risk
• Benefit-Risk BLOG

If you have an interest in being involved in this SIG or have an interesting case study or experience of carrying out a structured Benefit-Risk assessment to share, please contact Alexander Schacht

email: Schacht_alexander@lilly.com

Our BLOG can be found under www.benefit-risk-assessment.com

Latest News


  • Stats Excellence in the Pharmaceutical Industry award 2017

    We are very pleased to announce that the winner of the 2017 Statistical Excellence in the Pharmaceutical Industry Award goes to Dr Michael O’Kelly, principal scientific advisor at QuintilesIMS.
    more»
  • PSI Conference - Winners of this year's Poster Prize

    The 2017 PSI conference was held in London last week with a record attendance and fantastic scientific content. For those of you who missed the Close of the Conference, Anna Berglind from AstraZeneca presented the winners of this year's Poster Prize. We had 53 posters, and the quality of posters was very high.
    more»
Show all news

EventsFuture Events


Chiltern Logo Horz_TaglineRegistered_Screen

Biostatistician / Senior Biostatistician

read more...

Resized PAREXEL Logo with Tagline_Small_Full Color

Senior/Principal Biostatistician

read more...

Merck Logo2

Associate Director, Biostatistician

read more...

Leeds-80x250

Medical Statistician / Senior Medical Statistician

read more...

Astrazeneca

Associate Director, Statistics Team leader - Early Clinical Development

read more...